Context Therapeutics Inc. (CNTX) Earnings
|
Expand Research on CNTX
| Next EPS Date | 8/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -66.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/26 |
Q126 | N/A | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/26 |
Q425 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.10 | -$0.09 | -$0.01 | N/A | N/A | N/A |  | | Details | |
| 8/6/25 |
Q225 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/25 | Q125 | -$0.05 | -$0.12 | +$0.07 | N/A | N/A | N/A | | | Details | |
| 3/20/25 |
Q424 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/25 |
Q424 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A |
